INFLAZOME
Inflazome is a biotech company that develops orally available drugs to address inflammatory diseases by targeting inflammasomes. The company's drugs block inflammasome signals, eliminating a root cause of inflammation, enabling healthcare institutions to avail targeted therapies for inflammatory diseases such as Parkinson's, Alzheimer's, atherosclerosis, and type 2 diabetes. The company was incorporated in 2016 and is headquartered in Dublin, Ireland.
INFLAZOME
Industry:
Biopharma Biotechnology Health Diagnostics
Founded:
2016-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.inflazome.com
Total Employee:
11+
Status:
Active
Contact:
+35316798591
Email Addresses:
[email protected]
Total Funding:
63.82 M USD
Technology used in webpage:
SPF LetsEncrypt Apache Euro Microsoft Exchange Online Office 365 Mail Akamai DNS
Similar Organizations
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Current Employees Featured
Founder
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Inflazome
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Inflazome
Fountain Healthcare Partners
Fountain Healthcare Partners investment in Series A - Inflazome
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Inflazome
Official Site Inspections
http://www.inflazome.com
- Host name: 172.67.205.102
- IP address: 172.67.205.102
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
